Clinical trial
Acamprosate to Reduce Symptoms of Alcohol Withdrawal
NCT00106106 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00106106 |
|---|---|
| Title | Acamprosate to Reduce Symptoms of Alcohol Withdrawal |
| Official title | Acamprosate for Central Nervous System Hyperexcitability and Neuroadaptation in Alcohol Withdrawal |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcohol-Related Disorders, Alcohol Dependence, Alcoholism, Healthy Volunteer |
| Intervention type | Drug, Procedure |
| Interventions | NMR-spectroscopy, Oral acamprosate |
| Enrollment | 56 |
| Start date | Mar 1, 2005 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Mar 21, 2005 |
| Last update posted | Jan 12, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: